dc.contributor.author | Georgakis, Marios K. | |
dc.contributor.author | Malik, Rainer | |
dc.contributor.author | Björkbacka, Harry | |
dc.contributor.author | Pana, Tiberiu A | |
dc.contributor.author | Demissie, Serkalem | |
dc.contributor.author | Ayers, Colby | |
dc.contributor.author | Elhadad, Mohamed A. | |
dc.contributor.author | Fornage, Myriam | |
dc.contributor.author | Beiser, Alexa | |
dc.contributor.author | Benjamin, Emelia J. | |
dc.contributor.author | Boekholdt, S Matthijs | |
dc.contributor.author | Engström, Gunnar | |
dc.contributor.author | Herder, Christian | |
dc.contributor.author | Hoogeveen, Ron C. | |
dc.contributor.author | Koenig, Wolfgang | |
dc.contributor.author | Melander, Olle | |
dc.contributor.author | Orho-Melander, Marju | |
dc.contributor.author | Schiopu, Alexandru | |
dc.contributor.author | Söderholm, Martin | |
dc.contributor.author | Wareham, Nick | |
dc.contributor.author | Ballantyne, Christie M. | |
dc.contributor.author | Peters, Annette | |
dc.contributor.author | Seshadri, Sudha | |
dc.contributor.author | Myint, Phyo Kyaw | |
dc.contributor.author | Nilsson, Jan | |
dc.contributor.author | de Lemos, James A. | |
dc.contributor.author | Dichgans, Martin | |
dc.date.accessioned | 2020-03-03T00:02:40Z | |
dc.date.available | 2020-03-03T00:02:40Z | |
dc.date.issued | 2019-09-27 | |
dc.identifier | 147240953 | |
dc.identifier | aaa2e72a-409b-4afd-b3eb-45828692664b | |
dc.identifier | 31476962 | |
dc.identifier | 85072718369 | |
dc.identifier.citation | Georgakis , M K , Malik , R , Björkbacka , H , Pana , T A , Demissie , S , Ayers , C , Elhadad , M A , Fornage , M , Beiser , A , Benjamin , E J , Boekholdt , S M , Engström , G , Herder , C , Hoogeveen , R C , Koenig , W , Melander , O , Orho-Melander , M , Schiopu , A , Söderholm , M , Wareham , N , Ballantyne , C M , Peters , A , Seshadri , S , Myint , P K , Nilsson , J , de Lemos , J A & Dichgans , M 2019 , ' Circulating monocyte chemoattractant protein-1 and risk of stroke : Meta-Analysis of Population-Based Studies Involving 17 180 Individuals ' , Circulation Research , vol. 125 , no. 8 , pp. 773-782 . https://doi.org/10.1161/CIRCRESAHA.119.315380 | en |
dc.identifier.issn | 0009-7330 | |
dc.identifier.other | Mendeley: d1072815-19de-32e2-8fa3-62869a0d0980 | |
dc.identifier.other | ORCID: /0000-0002-1423-8111/work/96652726 | |
dc.identifier.uri | https://hdl.handle.net/2164/13769 | |
dc.description | M. Georgakis is funded by scholarships from the German Academic Exchange Service (DAAD) and Onassis Foundation. The ARIC study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I). The DHS study was funded by a grant from the Donald W. Reynolds Foundation. The EPIC-Norfolk study is funded by grants from the Medical Research Council UK (G9502233, G0401527) and Cancer Research UK (C864/A8257, C864/A2883). FHS is supported by the National Heart, Lung and Blood Institute’s Framingham Heart Study (Contract No. N01-HC-25195 and No. HHSN268201500001I and 75N92019D00031), received funding by grants from the National Institute of Aging (R01s AG054076, AG049607, AG059421, U01-AG049505, AG058589 and AG052409) and the National Institute of Neurological Disorders and Stroke (R01 NS017950, UH2 NS100605), as well as grants for the MCP-1 measurements by NIH (1RO1 HL64753, R01 HL076784, 1 R01 AG028321). The KORA study was initiated and financed by the Helmholtz Zentrum München – German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universität, as part of LMUinnovativ. The MDCS-CV study has been supported with funding from the Swedish Research Council, Swedish Heart and Lung Foundations, and the Swedish Foundation for Strategic Research. This project has received funding from the European Union’s Horizon 2020 research and innovation programme (No 666881), SVDs@target (to M. Dichgans) and No 667375, CoSTREAM (to M. Dichgans); the DFG as part of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy – ID 390857198) and the CRC 1123 (B3) (to M. Dichgans); the Corona Foundation (to M. Dichgans); the Fondation Leducq (Transatlantic Network of Excellence on the Pathogenesis of Small Vessel Disease of the Brain)(to M. Dichgans); the e:Med program (e:AtheroSysMed) (to M. Dichgans) and the FP7/2007-2103 European Union project CVgenes@target (grant agreement number Health-F2-2013-601456) (to M. Dichgans). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. | en |
dc.format.extent | 10 | |
dc.format.extent | 411474 | |
dc.format.extent | 327808 | |
dc.format.extent | 105702 | |
dc.format.extent | 189520 | |
dc.format.extent | 514819 | |
dc.language.iso | eng | |
dc.relation.ispartof | Circulation Research | en |
dc.subject | monocyte chemoattractant protein-1 | en |
dc.subject | CCL2 | en |
dc.subject | stroke | en |
dc.subject | cerebrovascular disease | en |
dc.subject | atherosclerosis | en |
dc.subject | R Medicine | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R | en |
dc.title | Circulating monocyte chemoattractant protein-1 and risk of stroke : Meta-Analysis of Population-Based Studies Involving 17 180 Individuals | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1161/CIRCRESAHA.119.315380 | |
dc.date.embargoedUntil | 2020-03-03 | |
dc.identifier.url | http://www.mendeley.com/research/circulating-monocyte-chemoattractant-protein1-risk-stroke-metaanalysis-populationbased-studies-invol | en |